The potential for oral combination chemotherapy of 5′-deoxy-5-fluorouridine, a 5-FU prodrug, and cyclophosphamide for metastatic breast cancer

Preclinical studies have demonstrated the synergistic anti-tumour activity of combination therapy with the oral cytostatics, 5′-deoxy-5-fluorouridine (5′-DFUR) and cyclophosphamide (CPA), in human breast cancer xenograft models. This study was performed to evaluate the efficacy and safety of this or...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yoshimoto, M, Tada, K, Tokudome, N, Kutomi, G, Tanabe, M, Goto, T, Nishimura, S, Makita, M, Kasumi, F
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2003
Témata:
Clinical
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2394400/
https://ncbi.nlm.nih.gov/pubmed/14583760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601350
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky